1 |
Herzog CE. Benign vascular tumors. In : Behrman RE, Kliegman RM, Jenson HB editors. Nelson textbook of pediatrics. 17th ed. Philadelphia : WB Saunders Co, 2004:1726
|
2 |
Park JH, Lee SJ, Koo SW, Lee JH, Kim YK, Choi GS. A case of diffuse neonatal hemangiomatosis. Korean J Dermatol 2001;39:617-20
|
3 |
MacArther CJ, Sinders CW, Katz J. The use of interferon alfa-2a for life threatening hemangiomas. Arch Otolaryngol Head Neck Surg 1995;121:117-20
|
4 |
Rowinsky EK, Donehower RC. The clinical pharmacology and use of antimicrotubule agents in cancer chemotherapeutics. Pharmacol Ther 1991;52:35-84
DOI
ScienceOn
|
5 |
Ramdohr M. Ein fall von angebornem multiplen angiosarcom. Virchows Arch Pathol Anat Histol 1878;73:459-60
DOI
|
6 |
Lopriore E, Markhorst DG. Diffuse neonatal hemangiomatosis : new views on diagnostic criteria and prognosis. Acta Paediatr 1999;88:93-7
|
7 |
Metry DW, Hebert AA. Benign cutaneous vascular tumors of infancy : when to worry, what to do. Arch Dermatol 2000;136:905-14
DOI
ScienceOn
|
8 |
Fawcett SL, Grant I, Hall PN, Kelsall AW, Nicholson JC. Vincristine as a treatment for a large haemangioma threatening vital functions. Br J Plast Surg 2004;57:168-71
DOI
ScienceOn
|
9 |
Stenninger E, Schollin J. Diffuse neonatal hemangiomatosis in a newborn child. Acta Paediatr 1993;82:102-4
|
10 |
Enjolras O, Breviere GM, Roger G, Tovi M, Pellegrino B, Varotti E, et al. Vincristine treatment for function- and life-threatening infantile hemangioma. Arch Pediatr 2004;11: 99-107
DOI
ScienceOn
|
11 |
Kim HJ, Kim NI. Diffuse neonatal hemangiomatosis. Ann Dermatol 2003;15:17-20
|
12 |
Castello MA, Ragni G, Antimi A, Todini A, Patti G, Lubrano R, et al. Successful management with interferon alpha-2a after prednisone therapy failure in an infant with a giant cavernous hemangioma. Med Pediatr Oncol 1997; 28:213-5
DOI
ScienceOn
|
13 |
Stratte EG, Tope WD, Johnson CL, Swanson NA. Multimodel management of diffuse neonatal hemangiomatosis. J Am Acad Dermatol 1996;34:337-42
DOI
ScienceOn
|
14 |
Michaud AP, Bauman NM, Burke DK, Manaligod JM, Smith RJH. Spastic diplegia and other motor disturbances in infants receiving interferon-alpha. Laryngoscope 2004;114:1231-6
DOI
ScienceOn
|
15 |
Cho HJ, Kim DK, Park KD, Yang CH, Lee JY, Kim KY. A case of diffuse neonatal hemangiomatosis improved with prednisolone and interferon alfa-2a. Korean J Dermatol 1996;34:1039-43
|
16 |
Golitz LE, Rudikoff J, O'Meara OP. Diffuse neonatal hemangiomatosis. Pediatr Dermatol 1986;3:145-52.
DOI
ScienceOn
|
17 |
Barlow CF, Priebe CJ, Mulliken JB, Barnes PD, Donald DM, Folkman J, et al. Spastic diplegia as a complication of interferon alfa-2a treatment of hemangiomas of infancy. J Pediatr 1998;132:527-30
DOI
PUBMED
ScienceOn
|
18 |
Seo YW, Lee SY, Lee JS, Whang KU, Lee HK. Diffuse neonatal hemangiomatosis successfully treated with high dose corticosteroid. Ann Dermatol 1998;10:112-5
|
19 |
Perez J, Pardo J, Gomez C. Vincristine-an effective treatment of corticoid-resistant life-threatening infantile hemangiomas. Acta Oncologica 2002;41:197-9
DOI
ScienceOn
|
20 |
Ho V, Krol A, Bhargava R, Osiovich H. Diffuse neonatal haemangiomatosis. J Paediatr Child Health 2000;36:286-9
DOI
ScienceOn
|